Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET and Oncotype Guided Neoadjuvant Therapy in Breast Cancer
NCT01641406Phase 2Unknown
- Sponsor
- Auxilio Mutuo Cancer Center
- Start
- Mar 2011
- Primary completion
- Jan 2013
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, epirubicin, cyclophosphamide, vinorelbine, bevacizumab in breast cancer, sponsored by Auxilio Mutuo Cancer Center. Status: unknown.
02
Drugs
docetaxelepirubicincyclophosphamidevinorelbinebevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01641406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641406.